Beren Therapeutics Funding: $300M Raised, Growth (2026)
Beren Therapeutics is based in Thousand Oaks, California. It has raised $300M in total funding. Latest round: Growth.
Beren Therapeutics funding overview
Beren Therapeutics is based in Thousand Oaks, California. Beren Therapeutics has raised $300M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Growth announced in June 2026. The round record for Beren Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include Wellington Partners, JIC Venture Growth Investments, Founders Fund, Narya Capital, Eisai Co., Ltd., Hercules Capital, Inc.. 6 distinct backers are named across the disclosed rounds.
Beren Therapeutics has raised $300M in total disclosed funding across the rounds on record.
Who has invested in Beren Therapeutics?
Wellington Partners, JIC Venture Growth Investments, Founders Fund, Narya Capital, Eisai Co., Ltd., Hercules Capital, Inc. are named among the investors backing Beren Therapeutics.
What was the latest Beren Therapeutics funding round?
The most recent disclosed round is a Growth, announced in June 2026.
Where is Beren Therapeutics based?
Beren Therapeutics is based in Thousand Oaks, California.
When did Beren Therapeutics last raise?
The last disclosed Beren Therapeutics round closed in June 2026 at Growth.
Every Beren Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Thousand Oaks at a similar stage.
